Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis

BACKGROUND/AIMS: We aimed to investigate the oral beclomethasone dipropionate’s (BDP) efficacy as an add-on therapy and to clarify the predictive factor for response to oral BDP in Korean ulcerative colitis (UC) patients. METHODS: Patients with a stable concomitant drug regimen with exposure to oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyuwon, Hong, Hee Seung, Oh, Kyunghwan, Lee, Jae Yong, Hong, Seung Wook, Park, Jin Hwa, Hwang, Sung Wook, Yang, Dong-Hoon, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Ye, Byong Duk, Park, Sang Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666248/
https://www.ncbi.nlm.nih.gov/pubmed/35730132
http://dx.doi.org/10.3904/kjim.2022.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666248/
https://www.ncbi.nlm.nih.gov/pubmed/35730132
http://dx.doi.org/10.3904/kjim.2022.035

Ejemplares similares